Amneal Pharmaceuticals, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 796.2M | 722.5M | 814.3M | 784.5M | 724.5M | 695.4M | 730.5M | 702.5M |
| Cost of Goods Sold | 461.7M | 402.4M | 517.1M | 510.5M | 438.3M | 439.5M | 467.6M | 432.9M |
| Gross Profit | 334.5M | 320.1M | 297.2M | 274.0M | 286.3M | 255.9M | 262.9M | 269.6M |
| R&D Expenses | 39.0M | 38.4M | 34.8M | 63.4M | 50.0M | 41.8M | 56.1M | 61.1M |
| Operating Expenses | 187.7M | 186.6M | 182.7M | 274.1M | 174.9M | 155.5M | 187.1M | 180.7M |
| Operating Income | -1.3M | 133.5M | 114.5M | -117K | 111.4M | 100.3M | 75.8M | 88.8M |
| Other Income / Gains | 72.3M | -53.4M | -59.3M | -5.1M | -59.7M | -62.9M | -91.1M | -73.4M |
| Net Income | 57.7M | 62.5M | 35.1M | 2.4M | 22.4M | 12.2M | -31.1M | -156K |
| EPS (Diluted) | 0.18 | 0.19 | 0.11 | 0.008 | 0.071 | 0.039 | -0.10 | -0.001 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.42 | 0.443 | 0.365 | 0.349 | 0.395 | 0.368 | 0.36 | 0.384 |
| General And Administrative Expenses | 0 | 186.6M | 0 | 0 | 0 | 0 | 94.3M | 0 |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 34.4M | 0 |
| Selling General And Administrative Expenses | 148.7M | 186.6M | 146.5M | 137.8M | 124.3M | 118.3M | 128.7M | 118.7M |
| Other Expenses | 0 | -38.4M | 1.4M | 72.9M | 634K | -4.6M | 2.3M | 960K |
| Cost And Expenses | 649.4M | 589.0M | 699.8M | 784.6M | 613.1M | 595.1M | 654.7M | 613.7M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | -55.0M | 53.4M | 56.2M | 62.8M | 65.1M | 56.9M | 61.7M | 65.5M |
| Depreciation And Amortization | 0 | 43.2M | 49.2M | 54.1M | 60.1M | 60.2M | 66.1M | 59.0M |
| Ebitda | -1.3M | 176.7M | 160.7M | 111.7M | 176.9M | 154.6M | 112.5M | 139.9M |
| Ebitdaratio | -0.002 | 0.245 | 0.197 | 0.142 | 0.244 | 0.222 | 0.154 | 0.199 |
| Operating Income Ratio | -0.002 | 0.185 | 0.141 | -0.00 | 0.154 | 0.144 | 0.104 | 0.126 |
| Income Before Tax | 71.0M | 80.2M | 55.2M | -5.2M | 51.7M | 37.5M | -15.3M | 15.4M |
| Income Before Tax Ratio | 0.089 | 0.111 | 0.068 | -0.007 | 0.071 | 0.054 | -0.021 | 0.022 |
| Income Tax Expense | 1.4M | 2.2M | 5.7M | -23.4M | 16.1M | 12.9M | 5.4M | 3.7M |
| Net Income Ratio | 0.072 | 0.086 | 0.043 | 0.003 | 0.031 | 0.018 | -0.043 | -0.00 |
| Epsdiluted | 0.18 | 0.19 | 0.11 | 0.008 | 0.07 | 0.038 | -0.10 | -0.001 |
| Weighted Average Shs Out | 319.2M | 328.9M | 313.4M | 314.2M | 313.7M | 311.1M | 309.9M | 309.6M |
| Weighted Average Shs Out Dil | 328.1M | 328.9M | 324.8M | 324.8M | 322.4M | 324.0M | 309.9M | 309.6M |